Around 3 weeks until the anticipated quarterly. It'll be nice to...

Around 3 weeks until the anticipated quarterly. It'll be nice to see a CF+ report ( which will include a small R&D rebate). I'm somewhat optimistic given (1), Ben snared a bit of stock, right on Xmas, and (2), the capital raise mentioned in the last quarterly appears to have been deferred.
Hopefully lessons have been learnt from past raises, I'd suggest the board are very reluctant to do a rights issue given how destructive it would be and the funding facility in place isn't efficient at low share prices and volumes.
The impression I get is not a desperation to raise, merely to have a cash back up given that revenue is " lumpy" and may not meet fixed cost demands on occasions.
A good report will ease concerns but will also have the spotlight on management to structure any potential funding very carefully.
There's been a lot of false starts, with the frustration built into the current price....again, we await...